Dr. Reddy’s Laboratories has appointed Marc Kikuchi as the Chief Executive Officer (CEO) of its North America Generics business. In his new role, Kikuchi will be responsible for overseeing the company’s North American generics operations, working out of the Princeton office in the United States.

With over 20 years of experience in the pharmaceutical industry, Marc Kikuchi brings a wealth of expertise to Dr. Reddy’s Laboratories. Known for his deep knowledge of generics, Kikuchi joins the company from Zydus Pharmaceuticals, where he served as CEO of the Americas since 2016. Prior to this, Kikuchi held senior leadership positions at prominent companies such as AmerisourceBergen, Medrad, PRTM, Johnson & Johnson, and Incyte Pharmaceuticals.

Marc Kikuchi expressed his enthusiasm about joining Dr. Reddy’s Laboratories, stating, “Dr. Reddy’s is a great company with a wide portfolio and remarkable heritage. I am excited to join Dr. Reddy’s and look forward to leveraging my past experiences to steer the Company’s new growth areas.” His appointment marks a significant step for Dr. Reddy’s Laboratories as it continues to strengthen its position in the generics market in North America.

Kikuchi’s educational background further reinforces his ability to lead in this space. He holds a Bachelor’s Degree in Molecular and Cell Biology with a Biochemistry emphasis from the University of California, Berkeley, and a Master of Business Administration (MBA) from Carnegie Mellon University, specialising in Strategy, Marketing, and Operations Management.